Secondary Hormone Therapy for Castration-Resistant Prostate Cancer

被引：0
作者：
Taplin, Mary-Ellen [1 ]
机构：
[1] Harvard Univ, Sch Med, Dana Farber Canc Inst, Lank Ctr Genitourinary Oncol, Boston, MA 02115 USA
来源：
ONCOLOGY-NEW YORK | 2013年 / 27卷 / 05期
关键词：
INCREASED SURVIVAL; ANDROGEN RECEPTOR; ABIRATERONE; CHEMOTHERAPY;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：371 / +
页数：3
相关论文
共 50 条
[41]   Activity of Cabazitaxel After Docetaxel and Abiraterone Acetate Therapy in Patients With Castration-Resistant Prostate Cancer [J].
Sella, Avishay ;
Sella, Tal ;
Peer, Avivit ;
Berger, Raanan ;
Frank, Stephen Jay ;
Gez, Eli ;
Sharide, David ;
Hayat, Henry ;
Hanovich, Ekaterina ;
Kovel, Svetlana ;
Rosenbaum, Eli ;
Neiman, Victoria ;
Keizman, Daniel .
CLINICAL GENITOURINARY CANCER, 2014, 12 (06) :428-432
[42]   Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer [J].
Ferrari, Anna C. ;
Alumkal, Joshi J. ;
Stein, Mark N. ;
Taplin, Mary-Ellen ;
Babb, James ;
Barnett, Ethan S. ;
Gomez-Pinillos, Alejandro ;
Liu, Xiaomei ;
Moore, Dirk ;
DiPaola, Robert ;
Beer, Tomasz M. .
CLINICAL CANCER RESEARCH, 2019, 25 (01) :52-63
[43]   Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer [J].
Sebastian Christoph Schmid ;
Alexander Geith ;
Alena Böker ;
Robert Tauber ;
Anna Katharina Seitz ;
Markus Kuczyk ;
Christoph von Klot ;
Jürgen Erich Gschwend ;
Axel Stuart Merseburger ;
Margitta Retz .
Advances in Therapy, 2014, 31 :234-241
[44]   Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy [J].
Ruiz, Belen Congregado ;
Belenchon, Ines Rivero ;
Cano, Guillermo Lendinez ;
Lopez, Rafael Antonio Medina .
BIOMEDICINES, 2023, 11 (04)
[45]   Enzalutamide After Docetaxel and Abiraterone Therapy in Metastatic Castration-Resistant Prostate Cancer [J].
Schmid, Sebastian Christoph ;
Geith, Alexander ;
Boeker, Alena ;
Tauber, Robert ;
Seitz, Anna Katharina ;
Kuczyk, Markus ;
von Klot, Christoph ;
Gschwend, Juergen Erich ;
Merseburger, Axel Stuart ;
Retz, Margitta .
ADVANCES IN THERAPY, 2014, 31 (02) :234-241
[46]   Drug therapies for metastatic castration-resistant prostate cancer [J].
El-Bahesh, Ehab ;
Finianos, Antoine ;
Alfaraj, Abeer ;
Aragon-Ching, Jeanny B. .
FUTURE ONCOLOGY, 2015, 11 (17) :2395-2403
[47]   Apalutamide for the treatment of patients with castration-resistant prostate cancer [J].
Hauke, R. .
DRUGS OF TODAY, 2018, 54 (10) :585-590
[48]   Emerging therapies targeting castration-resistant prostate cancer [J].
Gkialas, Ioarmis K. ;
Fragkoulis, Charalampos .
JOURNAL OF BUON, 2015, 20 (06) :1389-1396
[49]   Molecular Characterization of Enzalutamide-treated Bone Metastatic Castration-resistant Prostate Cancer [J].
Efstathiou, Eleni ;
Titus, Mark ;
Wen, Sijin ;
Hoang, Anh ;
Karlou, Maria ;
Ashe, Robynne ;
Tu, Shi Ming ;
Aparicio, Ana ;
Troncoso, Patricia ;
Mohler, James ;
Logothetis, Christopher J. .
EUROPEAN UROLOGY, 2015, 67 (01) :53-60
[50]   The role of enzalutamide in the treatment of castration-resistant prostate cancer [J].
Rawlinson, Alex ;
Mohammed, Aza ;
Miller, Marek ;
Kunkler, Roger .
FUTURE ONCOLOGY, 2012, 8 (09) :1073-1081
12345